back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-11-25 08:31 Tx date 2025-11-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Johnson, Craig
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+14,592 vol |
14,592 | |
| Filed 2025-11-25 08:29 Tx date 2024-11-07 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Johnson, Craig
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-25 08:28 Tx date 2025-11-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Johnson, Craig
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
-20,631 vol |
0 | |
| Filed 2025-11-25 08:24 Tx date 2025-11-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bailey, Jeff
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+9,419 vol |
22,775 | |
| Filed 2025-11-25 08:21 Tx date 2025-11-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Bailey, Jeff
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
-12,135 vol |
0 | |
| Filed 2025-08-06 13:15 Tx date 2025-08-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,022,233
+87,520 vol $11.68 each |
4,957,789 | |
| Filed 2025-08-06 13:14 Tx date 2025-08-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$496,238
+43,760 vol $11.34 each |
4,870,269 | |
| Filed 2025-08-06 13:13 Tx date 2025-08-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,428,512
+437,600 vol $10.12 each |
4,826,509 | |
| Filed 2025-08-06 13:12 Tx date 2025-08-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,313,766
+112,480 vol $11.68 each |
6,371,711 | |
| Filed 2025-08-06 13:11 Tx date 2025-08-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$637,761
+56,240 vol $11.34 each |
6,259,231 | |
| Filed 2025-08-06 12:33 Tx date 2025-08-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,691,488
+562,400 vol $10.12 each |
6,202,991 | |
| Filed 2025-08-06 12:32 Tx date 2025-08-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners III, Inc. (Control or Direction)
|
Common Shares
97 - Other
|
-500,000 vol |
0 | |
| Filed 2025-08-06 12:31 Tx date 2025-08-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
97 - Other
|
+500,000 vol |
5,640,591 | |
| Filed 2025-08-05 16:21 Tx date 2025-08-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Keenan, Greg
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-210,000
-20,000 vol $10.50 each |
8,719 | |
| Filed 2025-08-01 18:41 Tx date 2025-08-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-219,592.8724
-22,286 vol $9.85 each |
0 | |
| Filed 2025-08-01 18:41 Tx date 2025-08-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$219,592
+22,286 vol $9.85 each |
22,286 | |
| Filed 2025-07-18 16:10 Tx date 2025-07-15 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-212,504.502
-23,982 vol $8.86 each |
0 | |
| Filed 2025-07-18 16:10 Tx date 2025-07-15 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$212,504
+23,982 vol $8.86 each |
23,982 | |
| Filed 2025-07-18 16:09 Tx date 2025-07-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-525,825.72
-59,055 vol $8.90 each |
0 | |
| Filed 2025-07-18 16:09 Tx date 2025-07-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$525,825
+59,055 vol $8.90 each |
59,055 |